Fri, March 18, 2022
Thu, March 17, 2022
Wed, March 16, 2022
Tue, March 15, 2022
Mon, March 14, 2022
Fri, March 11, 2022
Thu, March 10, 2022
Wed, March 9, 2022

Oren Livnat Maintained (CARA) at Strong Buy with Decreased Target to $30 on, Mar 14th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-30-on-mar-14th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Oren Livnat of HC Wainwright & Co., Maintained "Cara Therapeutics, Inc." (CARA) at Strong Buy with Decreased Target from $35 to $30 on, Mar 14th, 2022.

Oren has made no other calls on CARA in the last 4 months.



There is 1 other peer that has a rating on CARA. Out of the 1 peers that are also analyzing CARA, 0 agree with Oren's Rating of Hold.



This is the rating of the analyst that currently disagrees with Oren


  • Jessica Fye of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $20 on, Tuesday, March 8th, 2022

Publication Contributing Sources